New Kentucky Laws on Schedule II Drug Prescriptions
Kentucky providers with prescriptive authority take note: beginning June 29, 2017, new laws (HB 333) go into effect that significantly impact the prescribing of Schedule II drugs. Schedule II drugs include brand names such as Demerol, OxyContin and Percocet.
Under provisions contained in the new law, if such drugs are being prescribed to treat a patient for pain as an acute medical condition, providers will be limited to prescribing no more than a three-day supply. In the wake of the national opioid epidemic, the new law is aimed at curbing the risk of persons recovering from surgeries and other medical procedures from becoming addicted to pain killers. The three-day limitation, though, is subject to a number of exceptions:
- In the provider’s professional judgment, more than a three day supply is necessary to treat the patient’s pain as an acute medical condition, which the provider adequately documents in the patient’s medical record.
- The drug is prescribed --
- To treat chronic pain as opposed to acute pain.
- To treat pain associated with a valid cancer diagnosis.
- To treat pain while the patient is receiving hospice or end-of-life treatment.
- As part of a state-licensed narcotic treatment program.
- To treat pain following a major surgery or the treatment of a significant trauma.
- The drug is dispensed or administered directly to an ultimate user in an inpatient setting.
The Kentucky Board of Medical Licensure (“KBML”), in conjunction with the state Office of Drug Control Policy, will be promulgating regulations to further define certain provisions in the new law; in particular, what constitutes “major surgery or the treatment of a significant trauma.” Also, the state Office of Inspector will be conducting quarterly reviews to identify patterns of potentially improper prescribing or dispensing of controlled drugs. Clearly, this new law places a burden on providers to familiarize themselves with the prescribing restriction and the various exceptions so they can remain in compliance while at the same time adequately meeting the treatment needs of their patients. For more information on this new law, contact James Dietz or any health care attorney at Frost Brown Todd.
Post a comment:
Ask the Blogger
Do you have a topic that you would like discussed in a future blog article? Please let us know. If you have a confidential question regarding a blog article, please feel free to contact the article's author directly, or let us know if you would like for someone to contact you directly.
James (Jim) A. Dietz is a Member at FBT who provides an array of legal services to hospitals, physicians, long-term care providers, diagnostic facilities, and others across the spectrum of patient care.